GCE® Launches Gascontrol.com Website Showcasing Its Complete Gas Control Portfolio for Speciality, Medical, and Industrial Applications
16.3.2026 14:00:00 EET | Business Wire | Press release
GCE®, a global market leader for gas control equipment, has launched gascontrol.com, a new website designed to better serve customers across its GCE Specialty, GCE Medical, and GCE Industrial product portfolios. The new site provides a streamlined, market-focused experience that makes it easier for users to explore GCE’s gas control solutions and identify the right products. A new Documentation Search Tool assists customers in easily finding documents such as instructions for use (IFUs), appendices, and certifications through an intuitive search interface.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316410525/en/
GCE’s new website, gascontrol.com, provides a streamlined, market-focused experience across the GCE Specialty, GCE Medical, and GCE Industrial product portfolios.
“The redesigned website reflects GCE’s role as a comprehensive, trusted supplier of gas control technologies that elevate industries and improve lives,” says Piyush Sheth, Vice President and General Manager, GCE. “With improved navigation, content organized by application and industry, and a list of global contacts, the site is intended to support engineers, clinicians, system designers, distributors, and procurement teams throughout the decision-making process.”
Three Product Groups
Backed by ESAB Corporation (NYSE: ESAB), GCE has grown its global footprint through the merging of leading gas-equipment providers, expanding its reach across the Americas, Asia, and Europe. Its products undergo rigorous testing and certifications to meet international quality and safety standards. GCE is organized into three product divisions:
GCE Speciality (gce-speciality.com) — incorporating the druva®, GASARC® and Victor®, brands — caters to high-purity market sectors such as pharmaceutical, semiconductor and automotive manufacturing, analytical laboratories, food and beverage, refrigeration, and industrial applications. GCE engineers regulators, manifolds, and other specialized products to maintain gas purity and deliver consistent, repeatable performance in environments where even minor contamination or pressure variation can impact results. GCE’s FloCloud digital solution enables users to monitor gas levels, detect gas leaks and confirm system integrity, monitor consumption, identify over-consumption, ensure gas flow and pressure are within limits for consistent quality, and allocate costs.
GCE Medical (gce-medical.com) — incorporating GCE Healthcare, Therapy Equipment, Ohio Medical, DeltaP and Aktiv Technologies brands — serves pre-hospital, hospital, emergency, and home care medical settings. Products include medical source gas equipment, medical high-pressure regulators, gas manifolds and pipeline systems, oxygen concentrators, ambulance panels, emergency equipment, and other products that ensure the safe and reliable delivery of life-supporting gases from source to patient.
GCE Industrial (gce-industrial.com) — incorporating the Kayser brand — has its origins in oxy fuel welding and cutting and has expanded into segments that use regulators, valves, central gas supply systems, cutting and welding torches and equipment, welding consumables, and safety gear. In industrial applications, the FloCloud Industry 4.0 gas monitoring solution reduces the costs and chance of error that comes from manually checking gas levels, reduces the cost of waste associated with parameters being out of specification, and reduces the chance of interrupted flow, and helps detect leaks.
About GCE
GCE Group, part of ESAB Corporation (NYSE: ESAB), is a leading global manufacturer of gas control equipment. Driven by innovation across our brands, including Ohio® Medical and Therapy Equipment, we strive to deliver the highest quality gas control products and services. Our portfolio offers market compliant, industry leading solutions for the medical, industrial and specialty gas industries. With international manufacturing, sales, and supply, we ensure customers can always access the world’s leading innovative gas control equipment. To learn more, visit https://www.gascontrol.com/en/about-us
PR-23132
View source version on businesswire.com: https://www.businesswire.com/news/home/20260316410525/en/
Contacts
ContactShaun Heys
Telephone+41 41 560 07 00
Cell+44 (0)7935 711 355
EmailShaun.heys@gcegroup.com
Websitewww.gcegroup.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.gcegroup.co
m&esheet=54448271&newsitemid=20260316410525&lan=en-US&anchor=www.gcegroup.com&in
dex=3&md5=c269aa14bf9688b837dc41340c16695f
ESAB Corporation Media Contact:
Tilea Coleman
Tel +1 (301) 323-9092
mediarelations@esab.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Capcom’s Resident Evil Requiem Sales Exceed 6 Million Units!16.3.2026 15:00:00 EET | Press release
Capcom Co., Ltd. (TOKYO:9697) today announced that worldwide sales of Resident Evil Requiem, released on February 27, 2026, now exceed 6 million units, which is the fastest that a title in the series has reached this milestone. Resident Evil Requiem is the latest installment in the Resident Evil series, which offers photorealistic visuals and a deep sense of immersion. Players can enjoy the elevated essence of the survival horror experience by the interplay between intense fear and exhilarating action, made possible by two protagonists. Going forward, Capcom plans to implement several measures, such as ongoing support and additional game content, so players can continue to enjoy the title longer. In addition, the Resident Evil series will celebrate its 30th anniversary on March 22,2026. Capcom is readying various plans for this anniversary to delight series fans, such as a collaboration between Universal Studios Japan and Resident Evil Requiem in 2026, and orchestral concerts in Japan,
Capcom’s Official Street Fighter 6 World Championship Tournaments Attract Record-high 20,000 Attendees16.3.2026 15:00:00 EET | Press release
Capcom Co., Ltd. (TOKYO:9697) today announced that Capcom Cup 12 and Street Fighter League: World Championship 2025, its official world championship tournaments to determine the top Street Fighter 6 competitors, which were held at Ryogoku Kokugikan Arena from March 11-15, achieved a record-high of 20,000 attendees, concluding with great success. At Capcom Cup 12, which features matches against individual players, SAHARA (21 years old), who is a first‑year professional player, claimed the championship title in his debut appearance, while in the team-based competition Street Fighter League: World Championship 2025, Japanese representatives REJECT were the winning team. Capcom additionally announced that it will hold next season’s Capcom Cup 13 and Street Fighter League: World Championship 2026 at Ryogoku Kokugikan Arena. Furthermore, the company will continue to offer a grand prize of $1 million for Capcom Cup and will increase the total prize pool for Street Fighter League from $200,000
Helical Fusion Announces Construction Site for Phase 1 of “Helix HARUKA,” Marking Transition to Manufacturing and Assembly of Fusion Hardware16.3.2026 15:00:00 EET | Press release
Helical Fusion Co., Ltd. (Head Office: Chuo-ku, Tokyo; CEO: Takaya Taguchi; “Helical Fusion”), a Japanese fusion energy company advancing the Helix Program and developing the Helical Stellarator for commercial fusion power plants, announced the construction site for Phase 1 of Helix HARUKA, its Integrated Demonstration Device. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316066384/en/ Concept image of Helix HARUKA, Helical Fusion’s integrated demonstration device Phase 1—the magnet demonstration phase—will be built in a dedicated workspace for the joint research group formed by Helical Fusion and the National Institute for Fusion Science (NIFS), located on the NIFS campus. Helical Fusion has already begun manufacturing phase and site build-out, with the aim of conducting coil current (energization) tests in 2027. It also highlights Helical Fusion’s role in leading a “Japan-style public–private partnership (PPP)” for fus
HyperLight Demonstrates Low-Power 1.6T-DR8 TFLN-based Reference Transceiver Assembled by TFC16.3.2026 14:03:00 EET | Press release
HyperLight Corporation (“HyperLight”) today announced a major milestone in low-power optical networking with the demonstration of a 1.6T-DR8 optical transceiver leveraging HyperLight’s TFLN Chiplet™ Platform. The reference module was demonstrated with engineering and manufacturing support from Suzhou TFC Optical Communication Co., Ltd. (SZSE: 300394, or "TFC"). The reference design achieves 20W power consumption in a fully retimed 1.6T-DR8 module, representing approximately 20% lower module-level power compared to alternative technologies. The reduction is achieved through a simple drop-in transmitter implementation based on a single thin-film lithium niobate photonic integrated circuit (TFLN PIC). The TFLN transmitter enables the module to operate using a single continuous-wave (CW) laser, compared to the two to four lasers typically required in conventional implementations. Additional energy savings are achieved through the ability to operate directly from the native low-swing electr
SBC Medical Announces Opening of Brand Flagship "NEO Skin Clinic Ginza."16.3.2026 14:00:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced that its specialized aesthetic brand, “NEO Skin Clinic,” will open its flagship location in Tokyo’s Ginza district, a globally recognized medical tourism hub and highly competitive district, on Saturday, March 28, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312457783/en/ SBC Medical Announces Opening of Brand Flagship "NEO Skin Clinic Ginza." The Ginza flagship, located in a prime area near GINZA SIX, will feature dedicated VIP rooms for executive clientele and the growing number of international patients, strengthening the brand’s global presence. Leveraging its robust network of 283 affiliated clinics (as of December 2025) and extensive clinical data, SBC Medical continues to advance its multi-bran
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom